Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
Clinical trial NCT04950127 · COMPLETED
Trial details
- NCT number
- NCT04950127
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-27
- Primary completion
- 2024-10-28
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.